News releases
Date
Language

Type of release


Download

Full announcement
Apr 30, 2012

Novo Nordisk A/S: Total number of voting rights and share capital in Novo Nordisk A/S as of 30 April 2012

In accordance with Section 6 of the Danish Statutory Order on Issuers' Disclosure Obligations, Novo Nordisk is required to publish the total number of voting rights and the size of the share capital in Novo Nordisk A/S as per the end of a month where changes therein have occurred.

Further information:

Media: Investors:
Anne Margrethe Hauge Klaus Bülow Davidsen
Tel: (+45) 4442 3450 Tel: (+45) 4442 3176
amhg@novonordisk.com klda@novonordisk.com
Frank Daniel Mersebach
Tel: (+45) 4442 0604
fdni@novonordisk.com
Lars Borup Jacobsen
Tel: (+45) 3075 3479
lbpj@novonordisk.com
In North America:
Ken Inchausti Jannick Lindegaard
Tel: (+1) 609 514 8316 Tel: (+1) 609 786 4575
kiau@novonordisk.com jlis@novonordisk.com

 Company Announcement No 30 / 2012